Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
In which CHD patients with high risk of CV complications are different doses of LIPRIMAR
 used? For this purpose, data on hyperlipidemia will be elicited over and above the basic
 nosographic and demographic data, concomitant diseases and cardiovascular risk factor.
Inclusion Criteria:

 -  Patients, who eligible to sign informed consent;

 -  Patients with indications to lipid lowing therapy, according to local product
 document.

 -  Patients with CHD and high risk of CV complications (Diabetes Mellitus II, Myocardial
 Infarction, Heart Failure, Arterial Hypertension, ets) will be included into study;

 -  Patients with LDL levels: > 3,5 mmol/l

 Exclusion Criteria:

 -  Individual intolerance of atorvastatin, in accordance to local product document.